Biomarkers for predicting degree of weight loss
AssigneeNestec S.A.
InventorsIrina Irincheeva, Jorg Hager, Loic Dayon, Ornella Cominetti
Life of this patent
Estimating the term…
Abstract
Biomarkers for predicting weight loss The present invention provides a method for predicting the degree of weight loss attainable by applying one or more dietary interventions to a subject, said method comprising; determining the level of one or more biomarkers in one or more samples obtained from the subject, wherein the one or more biomarkers include vitamin K-dependent protein C.
Claims17
A method for predicting the degree of weight loss attainable by applying one or more dietary interventions to a subject, the method comprising:
- determining the level of one or more biomarkers in one or more samples obtained from the subject, wherein the one or more biomarkers include vitamin K-dependent protein C.
(canceled)
A method for predicting the body mass index that a subject would be expected to attain from a dietary intervention (BMI2), wherein the method comprises:
- a. determining the level of vitamin K-dependent protein C;
- coagulation factor XIII A chain;
- pigment epithelium-derived factor;
- serum amyloid P-component;
- neuroligin-4, X-linked;
- CD226 antigen;
- metalloproteinase inhibitor 3;
- eukaryotic translation initiation factor 4E-binding protein 2;
- leukocyte immunoglobulin-like receptor subfamily B member 2;
- X-ray repair cross-complementing protein 6;
- caspase-2;
- interleukin-34;
- interleukin-17 receptor C;
- protein Z-dependent protease inhibitor;
- serum paraoxonase/arylesterase 1;
- plasminogen;
- complement factor D;
- leptin;
- carbonic anhydrase 6;
- macrophage metalloelastase and angiopoietin-1 in one or more samples obtained from the subject;
- and
- b. predicting BMI2 using formula (1):
- BMI2=c1*BMI1+c2*age−c3*Vitamin K-dependent protein C−c4*Coagulation factor XIII A chain−c5*Pigment epithelium-derived factor−c6*Serum amyloid P-component−c7*Neuroligin-4,X-linked−c8*CD226 antigen−c9*Metalloproteinase inhibitor 3−c10*Eukaryotic translation initiation factor 4E-binding protein 2+c11*Leukocyte immunoglobulin-like receptor subfamily B member 2+c12*X-ray repair cross-complementing protein 6+c13*Caspase-2+c14*Interleukin-34+c15*Interleukin-17 receptor C−c16*Protein Z-dependent protease inhibitor−c17*Serum paraoxonase/arylesterase 1+c18*Plasminogen−c19*Complement factor D+c20*Leptin−c21*Carbonic anhydrase 6+c22*Macrophage metalloelastase−c23*Angiopoietin-1;
- (1)
- wherein BMI1 is the subject's body mass index before the dietary intervention and BMI2 is the subject's predicted body mass index after the dietary intervention;
- and
- wherein c1 to c23 are positive integers.
A method for selecting a modification of lifestyle of a subject, the method comprising:
- a. performing a method for predicting the degree of weight loss attainable by applying one or more dietary interventions to a subject, the method comprising determining the level of one or more biomarkers in one or more samples obtained from the subject, wherein the one or more biomarkers include vitamin K-dependent protein C;
- and
- b. selecting a suitable modification in lifestyle based upon the degree of weight loss predicted in step (a).
17-26. (canceled)
Dependencies are inferred from the claim text.